Stephen J. Mcandrew serves as Executive at Oncobiologics, Inc., where they oversee executive responsibilities. Since joining the company, Stephen J. Mcandrew has executed 7 insider transactions totaling $97.9K, demonstrating a bearish approach to their equity position. Their most recent transaction on Dec 2, 2025 involved selling 6,446 shares valued at $0.
Stephen J. Mcandrew currently holds 6,446 shares of Oncobiologics, Inc. (ONS), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Stephen J. Mcandrew has been a net seller of ONS stock. They have purchased $0 and sold $97.9K worth of shares.
Stephen J. Mcandrew's most recent insider trade was on Dec 2, 2025, when they sold 6,446 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Dec 22, 2017 | ONS | $17.7K | Sale | 15,705 | $1.13 | Discretionary |
| Dec 21, 2016 | ONS | $0 | Award | 30,000 | $N/A | Discretionary |
| Nov 11, 2016 | ONS | $80.1K | Sale | 21,367 | $3.75 | Discretionary |
| Nov 9, 2016 | ONS | $0 | Option Exercise | 57,971 | $N/A | Discretionary |
| Nov 9, 2016 | ONS | $0 | Conversion | 57,971 | $N/A | Discretionary |